Advertisement

August 2022

Volume 298Issue 8
Open Access
On The Cover: Artistic rendering of lipoprotein lipase --GPI-anchored high density lipoprotein binding protein 1 fusion protein (LPL--GPIHBP1) lowering plasma triglycerides by breaking down chylomicrons. Nimonkar et al., pages 2900-2912, showed that the LPL--GPIHBP1 fusion protein has potential as a therapeutic for lowering plasma triglycerides in patients with chylomicronemia. The figure is based on the crystal structure of LPL/GPIHBP1 complex solved by the authors (Proc Natl Acad Sci U S A, 2019, 116, 10360-10365). Figure credit: Alan Abrams...
On The Cover: Artistic rendering of lipoprotein lipase --GPI-anchored high density lipoprotein binding protein 1 fusion protein (LPL--GPIHBP1) lowering plasma triglycerides by breaking down chylomicrons. Nimonkar et al., pages 2900-2912, showed that the LPL--GPIHBP1 fusion protein has potential as a therapeutic for lowering plasma triglycerides in patients with chylomicronemia. The figure is based on the crystal structure of LPL/GPIHBP1 complex solved by the authors (Proc Natl Acad Sci U S A, 2019, 116, 10360-10365). Figure credit: Alan Abrams
  • Cover

    Published in issue: August 2022
    102390

JBC Reviews

Accelerated Communications

Methods and Resources

Bioenergetics

Cell Biology

Computational Biology

Developmental Biology

DNA and Chromosomes

Enzymology

Gene Regulation

Glycobiology and Extracellular Matrices

Immunology

Lipids

Membrane Biology

Metabolism

Microbiology

Molecular Bases of Disease

Molecular Biophysics

Neurobiology

Protein Structure and Folding

Protein Synthesis and Degradation

RNA

Signal Transduction

Additions and Corrections

Withdrawals/Retractions

Advertisement